For periods between 24 and 72 hours mass cultures of hamster embryo cells were put in contact with the following carcinogens: 7,10-dimethylbenz (c) acridine (2 mug/ml), benzo (a) pyrene (0,1 mug/ml), 7-methyl benz (a) anthracene (5 and 10 mug/ml), 3-methyl-cholanthrene (0,1 mum/ml), and 7,12-dimethyl benz (a) anthracene (0,05 mug/ml). The cancerisation of cells thus treated was demonstrated by hamster grafting as soon as 4 1/2 months post-treatment. By contrast neither the cells treated by benzo (e) pyrene (non-carcinogenic in animals) nor those of the two control lines resulted in tumours when grafted into hamsters even after culture for 8 and 15 months. These transformed and malignant cultures differ from the controls by their rapid uncontrolled growth and in their morphology. Moreover the morphological characteristics of transformation are evident as soon as 2 months after treatment and for the majority of the compounds studied well before cancerization is demonstrable by hamster grafts. During the course of the first 2 months toxic effects of the compounds are evident in the partial destruction of the cultures and by the appearance of colonies composed in part of cells in disorderly growth. The cells of these colonies when isolated and returned to culture do not survive beyond 4 or 5 passages. Moreover grafts of cultures at 30 days after exposure to carcinogens has never resulted in tumour in the hamster host.
Download full-text PDF |
Source |
---|
Arch Virol
December 2024
Department of Medical Entomology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Most members of the genus Orthonairovirus, represented by Crimean-Congo hemorrhagic fever virus and Nairobi sheep disease virus, are tick-borne, and some have become a public health concern in recent years. Here, we report the isolation and genetic and biological characterization of a new orthonairovirus, designated as "Iwanai Valley virus" (IWVV), from Ixodes ovatus ticks in Hokkaido, Japan. The amino acid sequence of the viral nucleoprotein (NP) was found to be 34-45% identical to those of known orthonairoviruses.
View Article and Find Full Text PDFBrain Res
February 2025
St. Michael's Hospital, Unity Health Toronto, Toronto, ON Canada; Institute of Medical Science and the Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.
A high number of COVID-19 patients report ongoing neurological impairments including headache, fatigue and memory impairments. Our understanding of COVID-19 disease mechanisms in the brain is limited and relies on post-mortem human tissues, in vitro studies in various cell lines (both human and animal) as well as preclinical studies in a variety of species. Notably the use of rats in the study of COVID-19 has been scarce in part due to early reports of low infectivity of the original Wuhan strain in mice and rats.
View Article and Find Full Text PDFDrug Chem Toxicol
August 2024
Experimental Teaching Center, School of Basic Medical Sciences, Naval Medical University, Shanghai, China.
The effects of XQ528 tartrate on the embryonic and fetal development of fertile Sprague-Dawley (SD) rats, along with their embryos and littermates, were evaluated using an embryo-fetus developmental toxicity assay. fertile SD rats exhibited no significant general toxic effects when administered doses of 0.25, 1.
View Article and Find Full Text PDFJ Gen Virol
August 2024
Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, India.
The extensive protein production in virus-infected cells can disrupt protein homeostasis and activate various proteolytic pathways. These pathways utilize post-translational modifications (PTMs) to drive the ubiquitin-mediated proteasomal degradation of surplus proteins. Protein arginylation is the least explored PTM facilitated by arginyltransferase 1 (ATE1) enzyme.
View Article and Find Full Text PDFBiochem Biophys Res Commun
December 2024
Biological and Chemical Research Center, Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093, Warsaw, Poland.
Human α1,4-galactosyltransferase (A4galt), a Golgi apparatus-resident GT, synthesizes Gb3 glycosphingolipid (GSL) and P1 glycotope on glycoproteins (GPs), which are receptors for Shiga toxin types 1 and 2. Despite the significant role of A4galt in glycosylation processes, the molecular mechanisms underlying its varied acceptor specificities remain poorly understood. Here, we attempted to elucidate A4galt specificity towards GSLs and GPs by exploring its interaction with GTs with various acceptor specificities, GP-specific β1,4-galactosyltransferase 1 (B4galt1) and GSL-specific β1,4-galactosyltransferase isoenzymes 5 and 6 (B4galt5 and B4galt6).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!